Treatment of Head and Neck Cancers Using Radiotherapy

Author:

Shun Leung Wan,Ming Hung Hing

Abstract

Radiotherapy is one of the major treatments for head and neck cancers. This chapter discusses the importance of radiotherapy in treating the common types of head and neck cancers, which can be used as a primary treatment or as a postoperative adjuvant treatment to increase the survival of head and neck cancer patients. Because head and neck cancers are likely to be closely surrounded by radiation-sensitive vital organs, the dosimetric superiority of intensity-modulated radiotherapy (IMRT) to achieve highly conformal dose to the planning target volume (PTV) and avoidance of organs at risk (OARs) helps maintain the cornerstone role of radiotherapy in treating the disease. The rationale of IMRT and the treatment planning technique are introduced. Treatment planning of radiotherapy is one of the key procedures in IMRT. The inverse planning process involves many decision-making steps, including PTV and OAR delineation, beam arrangement settings, objective function setting, etc. These important steps are all illustrated in the chapter, with a specific discussion of planning challenges relevant to head and neck cancers. Finally, the promises for further development of IMRT in terms of OARs dose sparing and PTV dose escalation are briefly discussed and reviewed.

Publisher

IntechOpen

Reference89 articles.

1. Hong Kong Cancer Registry. Nasopharyngeal Cancer in 2016. 2016. Available from: http://www3.ha.org.hk/cancereg/facts.html

2. Ng WT, Wong ECY, Lee VHF, Chan JYW, Lee AWM. Head and neck cancer in Hong Kong. Japanese Journal of Clinical Oncology. 2018;48(1):13-21

3. Shield KD, Ferlay J, Jemal A, et al. The global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2012. CA: A Cancer Journal for Clinicians. 2017;67(1):51-64

4. Ferlay J, Ervik M, Lam F. Nasopharynx fact sheet: GLOBOCAN 2018. 2018. Available from: http://gco.iarc.fr/today/data/factsheets/cancers/4-Nasopharynx-fact-sheet.pdf

5. Chua MLKD, Wee JTSF, Hui EPF, Chan ATCP. Nasopharyngeal carcinoma. Lancet. 2015;387(10022):1012-1024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3